Veltuzumab

Tax included
Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody. Veltuzumab has low EC50 value of 0.08-0.09 μg/mL in the Daudi cell line. Veltuzumab can be used for the research of cancer including non-Hodgkin lymphoma (NHL).
MedChemExpress 
HY-P99224

Data sheet

Size
Multiple sizes
Reactivity
Integrin
Application
Cancer-programmed cell death
CAS
728917-18-8